Immediate Delivery is Indicated
This patient requires immediate delivery given she is at 37 weeks gestation with severe hypertension and absent end-diastolic flow (AEDF) on umbilical artery Doppler. 1
Clinical Reasoning
This patient presents with:
- Severe hypertension (160/100 mmHg) at 37 weeks gestation
- Irritability suggesting possible neurological involvement
- Fundal height discrepancy (35 weeks at 37 weeks GA) indicating fetal growth restriction
- Absent end-diastolic flow on umbilical artery Doppler
This constellation of findings represents preeclampsia with fetal growth restriction and severely abnormal placental function. 1
Immediate Management Steps
1. Admit to Hospital Immediately
- All women with preeclampsia should be assessed in hospital when first diagnosed 1
- The presence of severe hypertension and AEDF mandates inpatient management 1
2. Initiate Antihypertensive Therapy
- Target blood pressure: diastolic 85 mmHg and systolic <160 mmHg 1
- First-line agents include:
- For hypertensive crisis (≥160/110 mmHg), use IV labetalol 1
3. Administer Magnesium Sulfate for Seizure Prophylaxis
- This patient has severe hypertension with neurological signs (irritability), which mandates MgSO4 for convulsion prophylaxis 1
4. Proceed to Delivery
The definitive indication for delivery is the combination of:
The ISSHP guidelines explicitly state that women with preeclampsia should be delivered at 37 weeks gestation, and that reversed end-diastolic flow (or absent flow) is an absolute indication for delivery regardless of other factors. 1
5. Mode of Delivery
Cesarean section is likely indicated given:
- Absent end-diastolic flow on Doppler 1
- Unfavorable cervix (only 1 cm dilated, though soft) 1
- Primigravida status with severe preeclampsia
- Fetal growth restriction
However, the cervical exam shows some favorable features (soft cervix, 1 cm dilation), so induction of labor could be considered if fetal monitoring is reassuring and the maternal condition is stable. 1 The decision should involve an experienced obstetrician. 1
Critical Monitoring Before Delivery
Maternal Assessment:
- Blood pressure monitoring every 15-30 minutes until controlled 1
- Laboratory tests immediately: complete blood count (platelets), liver transaminases, creatinine, uric acid 1
- Clinical assessment for clonus, visual symptoms, severe headache 1
- Urine protein quantification if not already done 1
Fetal Assessment:
- Continuous cardiotocography given AEDF 1
- Ultrasound assessment of amniotic fluid volume 1
- The fundal height discrepancy (35 weeks at 37 weeks) confirms fetal growth restriction 1
Why Immediate Delivery is Non-Negotiable
At 37 Weeks with AEDF:
The ISSHP guidelines state that in cases of absent end-diastolic flow, delivery should be considered no later than 34 weeks gestation. 1 This patient is already at 37 weeks, which is 3 weeks beyond the recommended delivery threshold for AEDF.
Perinatal Risk with AEDF:
Research demonstrates that AEDF carries extremely high perinatal mortality (approaching 60% in some studies) when delivery is delayed. 2, 3, 4 One landmark study showed that all perinatal deaths occurred in fetuses with reversed flow, and that AEDF "always precedes the appearance of fetal distress." 2
Term Gestation Eliminates Prematurity Concerns:
At 37 weeks, the fetus is term, eliminating concerns about prematurity that might justify expectant management at earlier gestations. 1
Common Pitfalls to Avoid
Do NOT attempt expectant management
- While some studies suggest AEDF can be observed for longer periods at earlier gestations 5, this patient is already at term with severe maternal hypertension 1
- The combination of severe preeclampsia + AEDF + term gestation = immediate delivery 1
Do NOT delay for "fetal lung maturity"
Do NOT use ACE inhibitors, ARBs, or direct renin inhibitors
- These are strictly contraindicated in pregnancy due to severe fetotoxicity 1
Do NOT underestimate the neurological risk
- The patient's "irritability" may represent evolving eclampsia 1
- Blood pressure ≥160/110 mmHg is a surrogate marker for stroke risk 1
Summary Algorithm
- Admit immediately 1
- Start antihypertensive therapy (labetalol, nifedipine, or methyldopa) targeting diastolic BP 85 mmHg 1
- Administer MgSO4 for seizure prophylaxis 1
- Obtain labs (CBC, liver enzymes, creatinine) and continuous fetal monitoring 1
- Deliver immediately - likely by cesarean section given AEDF and unfavorable cervix 1